SECOND-LINE THERAPY

Clinical trials for SECOND-LINE THERAPY explained in plain language.

Never miss a new study

Get alerted when new SECOND-LINE THERAPY trials appear

Sign up with your email to follow new studies for SECOND-LINE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for Tough-to-Treat thymic cancer patients

Disease control Not yet recruiting

This study is testing whether a new drug called sacituzumab tirumotecan can help control advanced thymic cancer in patients whose disease has continued to grow despite receiving at least one prior treatment. The trial will enroll 38 adults to receive the drug by IV every two week…

Matched conditions: SECOND-LINE THERAPY

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

SECOND-LINE THERAPY

Get alerted when new SECOND-LINE THERAPY trials appear

New hope for Tough-to-Treat thymic cancer patients